Novel method for homogeneous gene transfer to the inner ear

2004 ◽  
Vol 124 (sup553) ◽  
pp. 19-22 ◽  
Author(s):  
Kazuma Sugahara ◽  
Hiroaki Shimogori ◽  
Takeshi Okuda ◽  
Tsuyoshi Takemoto ◽  
Hiroshi Yamashita
Keyword(s):  
2000 ◽  
Vol 59 (1) ◽  
pp. 45-51
Author(s):  
Tatsuya Yamasoba ◽  
Masao Yagi ◽  
Mitsuya Suzuki

Leukemia ◽  
1999 ◽  
Vol 13 (10) ◽  
pp. 1608-1616 ◽  
Author(s):  
DS Howard ◽  
DA Rizzierri ◽  
B Grimes ◽  
D Upchurch ◽  
GL Phillips ◽  
...  

2005 ◽  
Vol 72 (2) ◽  
pp. 309-315 ◽  
Author(s):  
Satoshi Watanabe ◽  
Masaki Iwamoto ◽  
Shun-ichi Suzuki ◽  
Daiichiro Fuchimoto ◽  
Daisuke Honma ◽  
...  

Author(s):  
John V. Brigande ◽  
Samuel P. Gubbels ◽  
David W. Woessner ◽  
Jonathan J. Jungwirth ◽  
Catherine S. Bresee
Keyword(s):  

Gene Therapy ◽  
2012 ◽  
Vol 20 (3) ◽  
pp. 237-247 ◽  
Author(s):  
R Sacheli ◽  
L Delacroix ◽  
P Vandenackerveken ◽  
L Nguyen ◽  
B Malgrange
Keyword(s):  

2014 ◽  
Vol 2014 ◽  
pp. 1-11 ◽  
Author(s):  
Ai-Ho Liao ◽  
Yi-Lei Hsieh ◽  
Hsin-Chiao Ho ◽  
Hang-Kang Chen ◽  
Yi-Chun Lin ◽  
...  

Gene therapy for sensorineural hearing loss has recently been used to insert genes encoding functional proteins to preserve, protect, or even regenerate hair cells in the inner ear. Our previous study demonstrated a microbubble- (MB-)facilitated ultrasound (US) technique for delivering therapeutic medication to the inner ear. The present study investigated whether MB-US techniques help to enhance the efficiency of gene transfection by means of cationic liposomes on HEI-OC1 auditory cells and whether MBs of different sizes affect such efficiency. Our results demonstrated that the size of MBs was proportional to the concentration of albumin or dextrose. At a constant US power density, using 0.66, 1.32, and 2.83 μm albumin-shelled MBs increased the transfection rate as compared to the control by 30.6%, 54.1%, and 84.7%, respectively; likewise, using 1.39, 2.12, and 3.47 μm albumin-dextrose-shelled MBs increased the transfection rates by 15.9%, 34.3%, and 82.7%, respectively. The results indicate that MB-US is an effective technique to facilitate gene transfer on auditory cellsin vitro. Such size-dependent MB oscillation behavior in the presence of US plays a role in enhancing gene transfer, and by manipulating the concentration of albumin or dextrose, MBs of different sizes can be produced.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Hiroki Takeda ◽  
Toru Miwa ◽  
Min Young Kim ◽  
Byung Yoon Choi ◽  
Yorihisa Orita ◽  
...  

AbstractThe otocyst, an anlage of the inner ear, presents an attractive target to study treatment strategies for genetic hearing loss and inner ear development. We have previously reported that electroporation-mediated transuterine gene transfer of Connexin30, utilizing a monophasic pulse into Connexin30−/− mouse otocysts at embryonic day 11.5, is able to prevent putative hearing deterioration. However, it is not clear whether supplementary gene transfer can rescue significant morphological changes, caused by genetic deficits. In addition, with the transuterine gene transfer technique utilized in our previous report, the survival rate of embryos and their mothers after treatment was low, which became a serious obstacle for effective in vivo experiments. Here, we set out to elucidate the feasibility of supplementation therapy in Slc26a4 deficient mice, utilizing biphasic pulses, optimized by modifying pulse conditions. Modification of the biphasic pulse conditions during electroporation increased the survival rate. In addition, supplementation of the target gene cDNA into the otocysts of homozygous Slc24a4 knockout mice significantly prevented enlargement of the endolymphatic space in the inner ear areas; moreover, it rescued hearing and vestibular function of mice in vivo.


Sign in / Sign up

Export Citation Format

Share Document